Serum Cholesterol and Gastric Neoplasm
SCGN
2 other identifiers
observational
1,178
1 country
1
Brief Summary
Investigators have a plan to conduct nested case-control study to investigate the association between serum cholesterol levels including TC, HDL-C, LDL-C, triglyceride (TG), apolipoproteins and gastric neoplasm. In addition, further analyses were performed to evaluate the possible role of the serum cholesterol as a predictor for the differentiation and prognosis of gastric neoplasm.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2014
CompletedFirst Posted
Study publicly available on registry
January 22, 2014
CompletedStudy Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedDecember 6, 2016
December 1, 2016
4.8 years
January 2, 2014
December 4, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cholesterol level in paitents with and withoutgastric neoplasm
Serum cholesterol levels including TC, HDL-C, LDL-C, triglyceride (TG), apolipoproteins will be checked and compared in paitents with and withoutgastric neoplasm.
up to 24 months
Secondary Outcomes (1)
Degree of decresed serum cholesterol levels in paitents with gastric neoplasm
up to 24 months
Study Arms (1)
Gastric cancer
No intervention
Interventions
Eligibility Criteria
All subjects who visited the department of gastroenterology, surgery, or Healthcare Screening \& Promotion Center at Asan Medical Center and diagnosed as gastric cancer
You may qualify if:
- All subjects who visited the department of gastroenterology, surgery, or Healthcare Screening \& Promotion Center at Asan Medical Center and diagnosed as gastric cancer
You may not qualify if:
- Subjects who has history about drug for cholesterol, diabetes, liver disease, and/or thyroid disease.
- Subjects who do not want to be enrolled this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center
Seoul, South Korea
Biospecimen
endoscopic biopsy specimen of gastric mucosa surgically resected specimen of stomach
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hwoon-Yong Jung, M.D., PhD.
Asan Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 2, 2014
First Posted
January 22, 2014
Study Start
February 1, 2014
Primary Completion
December 1, 2018
Study Completion
June 1, 2019
Last Updated
December 6, 2016
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will not share